DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Soto Parra H, Cavina R, Latteri F. et al.
Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.
Ann Oncol 2002; 13: 1080-1086
We do not assume any responsibility for the contents of the web pages of other providers.